{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:45:53Z","timestamp":1793508353932,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7172134 and 7192128"],"award-info":[{"award-number":["7172134 and 7192128"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8197268"],"award-info":[{"award-number":["8197268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PUMC Youth Fund and Fundamental Research Funds for the Central Universities","award":["3332015113 and 2017350002"],"award-info":[{"award-number":["3332015113 and 2017350002"]}]},{"name":"National Science and Technology Major Projects for Major New Drugs Innovation and Development","award":["2019ZX09301170"],"award-info":[{"award-number":["2019ZX09301170"]}]},{"name":"CMAS Innovation Fund for Medical Sciences","award":["2021-I2M-1-026"],"award-info":[{"award-number":["2021-I2M-1-026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite tremendous success of molecular targeted therapy together with immunotherapy, only a small subset of patients can benefit from them. Chemotherapy remains the mainstay treatment for most of tumors including non-small cell lung cancer (NSCLC); however, non-selective adverse effects on healthy tissues and secondary resistance are the main obstacles. Meanwhile, the quiescent or dormant cancer stem-like cells (CSLCs) are resistant to antimitotic chemoradiotherapy. Complete remission can only be realized when both proliferative cancer cells and quiescent cancer stem cells are targeted. In the present research, we constructed a cooperatively combating conjugate (DTX-P7) composed of docetaxel (DTX) and a heptapeptide (P7), which specifically binds to cell surface Hsp90, and assessed the anti-tumor effects of DTX-P7 on non-small cell lung cancer. DTX-P7 preferentially suppressed tumor growth compared with DTX in vivo with a favorable distribution to tumor tissues and long circulation half-life. Furthermore, we revealed a distinctive mechanism whereby DTX-P7 induced unfolded protein response and eventually promoted apoptosis. More importantly, we found that DTX-P7 promoted cell cycle reentry of slow-proliferating CSLCs and subsequently killed them, exhibiting a \u201cproliferate to kill\u201d pattern. Collecitvely, by force of active targeting delivery of DTX via membrane-bound Hsp90, DTX-P7 induces unfolded protein response and subsequent apoptosis by degrading Hsp90, meanwhile awakens and kills the dormant cancer stem cells. Thus, DTX-P7 deserves further development as a promising anticancer therapeutic for treatment of various membrane-harboring Hsp90 cancer types.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13045-022-01274-8","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T10:03:45Z","timestamp":1654250625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["DTX-P7, a peptide\u2013drug conjugate, is highly effective for non-small cell lung cancer"],"prefix":"10.1186","volume":"15","author":[{"given":"Yao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"1274_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/2472555220912955","volume":"25","author":"L Gauzy-Lazo","year":"2020","unstructured":"Gauzy-Lazo L, Sassoon I, Brun MP. Advances in antibody\u2013drug conjugate design: current clinical landscape and future innovations. SLAS Discov. 2020;25(8):843\u201368. https:\/\/doi.org\/10.1177\/2472555220912955.","journal-title":"SLAS Discov"},{"issue":"8","key":"1274_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/molecules22081281","volume":"22","author":"H Chen","year":"2017","unstructured":"Chen H, Lin ZT, Arnst KE, Miller DD, Li W. Tubulin inhibitor-based antibody-drug conjugates for cancer therapy. Molecules. 2017;22(8):1281. https:\/\/doi.org\/10.3390\/molecules22081281.","journal-title":"Molecules"},{"key":"1274_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2015.11.029","volume":"221","author":"Y Jiang","year":"2016","unstructured":"Jiang Y, Yang N, Zhang HF, Sun B, Hou CY, Ji C, et al. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition. J Control Release. 2016;221:26\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2015.11.029.","journal-title":"J Control Release"},{"issue":"19","key":"1274_CR4","doi-asserted-by":"publisher","first-page":"10317","DOI":"10.3390\/ijms221910317","volume":"22","author":"B Birbo","year":"2021","unstructured":"Birbo B, Madu EE, Madu CO, Jain A, Lu Y. Role of HSP90 in cancer. Int J Mol Sci. 2021;22(19):10317. https:\/\/doi.org\/10.3390\/ijms221910317.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"1274_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1389450120666190829162544","volume":"21","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Liu Y. Recent advances in the discovery of novel HSP90 inhibitors: an update from 2014. Curr Drug Targets. 2020;21(3):302\u201317. https:\/\/doi.org\/10.2174\/1389450120666190829162544.","journal-title":"Curr Drug Targets."},{"issue":"13","key":"1274_CR6","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.1074\/jbc.M112.437897","volume":"288","author":"WS Chen","year":"2013","unstructured":"Chen WS, Chen CC, Chen LL, Lee CC, Huang TS. Secreted heat shock protein 90\u03b1 (HSP90\u03b1) induces nuclear factor-\u03baB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion. J Biol Chem. 2013;288(13):9001\u201310. https:\/\/doi.org\/10.1074\/jbc.M112.437897.","journal-title":"J Biol Chem."},{"issue":"3","key":"1274_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbamcr.2011.09.009","volume":"1823","author":"W Li","year":"2012","unstructured":"Li W, Sahu D, Tsen F. Secreted heat shock protein-90 (Hsp90) in wound healing and cancer. Biochim Biophys Acta. 2012;1823(3):730\u201341. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.09.009.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1274_CR8","doi-asserted-by":"publisher","first-page":"15108","DOI":"10.1038\/s41598-019-51704-w","volume":"9","author":"X Tang","year":"2019","unstructured":"Tang X, Chang C, Guo J, Lincoln V, Liang C, Chen M, et al. Tumour-secreted Hsp90\u03b1 on external surface of exosomes mediates tumour - stromal cell communication via autocrine and paracrine mechanisms. Sci Rep. 2019;9(1):15108. https:\/\/doi.org\/10.1038\/s41598-019-51704-w.","journal-title":"Sci Rep."},{"key":"1274_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.735529","volume":"9","author":"P Poggio","year":"2021","unstructured":"Poggio P, Sorge M, Secl\u00ec L, Brancaccio M. Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Front Cell Dev Biol. 2021;9:735529. https:\/\/doi.org\/10.3389\/fcell.2021.735529.","journal-title":"Front Cell Dev Biol."},{"key":"1274_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/bs.acr.2016.01.001","volume":"129","author":"DS Wong","year":"2016","unstructured":"Wong DS, Jay DG. Emerging roles of extracellular Hsp90 in cancer. Adv Cancer Res. 2016;129:141\u201363. https:\/\/doi.org\/10.1016\/bs.acr.2016.01.001.","journal-title":"Adv Cancer Res."},{"key":"1274_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fonc.2017.00078","volume":"7","author":"M Corazzari","year":"2017","unstructured":"Corazzari M, Gagliardi M, Fimia GM, Piacentini M. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol. 2017;7:78. https:\/\/doi.org\/10.3389\/fonc.2017.00078.","journal-title":"Front Oncol."},{"issue":"7","key":"1274_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/cas.12958","volume":"107","author":"S Takeishi","year":"2016","unstructured":"Takeishi S, Nakayama KI. To wake up cancer stem cells, or to let them sleep, that is the question. Cancer Sci. 2016;107(7):875\u201381. https:\/\/doi.org\/10.1111\/cas.12958.","journal-title":"Cancer Sci"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-022-01274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-022-01274-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-022-01274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T10:26:52Z","timestamp":1654252012000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-022-01274-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1274"],"URL":"https:\/\/doi.org\/10.1186\/s13045-022-01274-8","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the animal experiments were approved by the Institutional Animal Care and Use Committee of the Chinese Academy of Medical Science and were conducted in accordance with the recommendations of \u201cRegulations of experimental animals.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}